Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program

Abstract Objective The aim of this study was to assess potential drug–drug interactions between highly purified cannabidiol (CBD) and anti‐seizure medications (ASMs). Methods Our group previously reported that in a sample of adults and children receiving CBD in an open‐label expanded access program,...

全面介绍

书目详细资料

Principais autores:	Tyler E. Gaston, E. Martina Bebin, Gary R. Cutter, Leslie Grayson, Jerzy P. Szaflarski
格式:	Artigo
语言:	Inglês
出版:	Wiley 2023-12-01
丛编:	Epilepsia Open
主题:	anti‐seizure medications cannabidiol drug interactions treatment‐resistant epilepsy
在线阅读:	https://doi.org/10.1002/epi4.12815
标签:	添加标签 没有标签, 成为第一个标记此记录!